Search Tag: antiplatelet therapy
2015 17 Mar
According to a study published in JAMA, an additional 18 months of dual antiplatelet therapy (DAPT) after coronary stent replacement did not result in any significant differences in rates of stent thrombosis, adverse cardiac and cerebrovascular events or bleeding, compared to placebo. Current guidelines recommended a minimum of 1 month of DAPT after...Read more
2013 01 Nov
A new study evaluating the effects of short-term (defined as three months) versus long-term (one year) dual antiplatelet therapy shows that the shorter duration treatment does not result in poorer outcomes on certain measures such as death, heart attack, stroke, and bleeding for patients with coronary artery disease or low-risk acute coronary syndromes...Read more